"There is a large gap between the rhetoric of a political system that preaches the Knowledge Society and the reality of budgetary and other priorities that have shown little shift in preparing to engage with it."
Esko Aho, former Prime Minister of Finland, in Creating an Innovative Europe, January 2006.
Ireland's fastest-growing companies hired even more aggressively than other top job-creating European companies during 2001-2004, according to a survey conducted by Entrepreneurs for Growth, a membership-based organisation representing 2,000 European firms.
TU Delft ditched the usual model of outlicensing or seeking venture capital backing when it was looking to commercialise a novel wastewater treatment technology.
Last month the world's leading pharmaceutical company received simultaneous FDA approval for two new therapies. Yet neither drug was invented by the company. Both were originally developed by small biotechs.
With high oil prices showing no sign of quitting, "cleantech" is the new darling VC investment sector. But, asks Mary Lisbeth D'Amico, is the market more froth than substance?
Not so much a geological specimen as something that will make nanotechnology happen, dendrimers are the young upstarts of the polymer family - but they have promise.
Nanotechnology has the power to transform healthcare. But Europe will lose out to the United States unless it can mount a coherent approach to developing nanomedicine, says a new report.
On 26 January, in London, Science|Business organised a roundtable of executives in the biotech industry to discuss the state of the market. The consensus: investor appetite for biotech companies is on the rise.
Scientists at the University of Manchester have invented an electronic nose that can monitor odours and methane at waste landfill and water treatment plants remotely.
Scientists at the John Innes plant research centre in Norwich, UK have uncovered a gene that could form the basis of new crop varieties able to cope with changes in world climate brought about by global warming.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.